Literature DB >> 6829500

Humoral and cellular studies of eosinophils in reactive and myeloproliferative syndromes with marked eosinophilia.

J P Crowley, T J Myers.   

Abstract

In five patients with eosinophilia and myeloproliferative disorders, the IgE levels were normal, and immune complexes were not detected. In contrast, in six patients with reactive eosinophilia accompanying immunologic diseases, the IgE levels were elevated in five, and immune complexes were elevated in two. Five of six patients within the reactive group had positive rheumatoid factor titers by latex agglutination, while only one of five in the myeloproliferative group showed this finding. Purified eosinophils from patients with myeloproliferative diseases showed enhanced oxygen consumption responses during the ingestion of latex beads, relative to reactive eosinophils. The stimulated oxidative response of reactive eosinophils during phagocytosis of bacteria opsonized with antibody and complement was reduced, relative to myeloproliferative eosinophils. In vitro incubation of eosinophils with immune complexes reduced, by more than two-thirds, the increased oxidative responses of myeloproliferative eosinophils. Our findings suggest that eosinophilia seen in myeloproliferative diseases is an intrinsic part of the myeloproliferative process, which is not mediated or enhanced by allergic or immunologic reactions. The measurements reported here have potential value for differentiating reactive eosinophilic states from the eosinophilia accompanying myeloproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6829500     DOI: 10.1093/ajcp/79.3.301

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  1 in total

Review 1.  Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis.

Authors:  Ayalew Tefferi; Animesh Pardanani
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.